Leonardino filled NAD patent on Europe, USA, Japan, Australia, Brazil, Arab Emirates, Japan, Russia, South Corea, India, South Africa, Singapore, Mexico, Israel and Canada.
Leonardino moved to its new headquarters, located in Via Ghisalba, 13 Bollate (MI), over 700 square meters of offices, R&D laboratories and medical devices manufacturing.
Leonardino is developing a new technology for drug delivery platform with functionalized nanomaterial, based on NAD, a patented medical devices of silk fibroin for chronic
NAD, Leonardino’s patented medical devices for chronic wounds, gets CE mark as class IIb medical device.
Leonardino’s quality system is now fully compliant to ISO 13485 for medical devices.
Leonardino moved to its new headquarters, located in Via Don Giovanni Minzoni, 29 20158 Milano, over 450 square meters of offices, laboratories and manufacturing.
Leonardino scale up its nanomaterial technology platform to an high-throughput system to start industrial production of nanomaterials for medical devices applications. NAD (Leonardino patented silk
Leonardino wishes all of you a Merry Christmas and a Happy New Year. Our team is on holiday until Monday, 4th January 2016. For any needs
Leonardino is working to get the certification UNI CEI EN ISO 13485:2012 in the first quarter 2016, in order to have a globally recognized quality
Leonardino updated website is now online: enjoy renewed graphics and new contents.